Le Lézard
Classified in: Health
Subject: MAT

How To Know If A Permanent Non-Surgical Nose Job Is Too Good To Be True by Eric M. Joseph, M.D.


WEST ORANGE, N.J., Jan. 6, 2020 /PRNewswire/ -- The non-surgical nose job is a little-known beauty savior promising natural, affordable and fast results without going under the knife.  If this sounds too good to be true, follow your nose. Not all non-surgical nose jobs are created equal.  Here's what you need to know.

Permanent non-surgical nose job with microdroplet Silikon-1000 for repair of a low nasal bridge after previous rhinoplasty surgery performed elsewhere.

Whether you're dissatisfied with the bump you were born with or devastated by a botched nose job, the non-surgical nose job is an effective option to improve your appearance safely, quickly and affordably.

People who are candidates for non-surgical nose jobs typically wish to camouflage a small bump, create a more symmetrical appearance or make their nostrils lower.  Some of the happiest patients treated with the non-surgical nose job are those who suffered from visible irregularities after a previous nose job.

The non-surgical nose job works by injecting filler to change the appearance of your nose. But the type of filler matters.  Many plastic surgeons performing non-surgical nose jobs use temporary gel fillers like hyaluronic acid (HA). But these costly treatments last only months and must be repeated to maintain the desired result.  That's too good to be true.

Eric M. Joseph, M.D. is a board-certified facial plastic surgeon who prefers permanent filler.  Dr. Joseph's expertise is with the microdroplet technique of administering Silikon®-1000 for permanent non-surgical results. Silikon®-1000 (purified polydimethylsiloxane) is FDA-approved medical grade silicone oil. The microdroplet technique is key to success. Dr. Joseph administers tiny droplets of filler at a time to achieve the desired result.

"Microdroplet Silikon®-1000 may be the safest option for people considering non-surgical nose job treatments, especially for those who have undergone previous rhinoplasty surgery", says Dr. Joseph who has performed over 1,000 nasal treatments with Silikon®-1000.  "In rare instances, temporary gel fillers may be associated with necrosis, biofilm, and blindness. But these severe complications have never been seen with microdroplet Silikon®-1000 injections."

While originally developed for certain eye diseases, microdroplet silicone oil has been used for permanent non-surgical nose job treatments in the US for over 50 years, with a consistent track record of safety, precision, and excellent results. Unlike the viscous silicone that made breast implants dangerous in the 1980s, silicone oil is ubiquitous in many medical devices. Hypodermic needles, disposable syringes, and IV catheters made in the US since WWII are coated with a thin layer of silicone for lubrication and patient comfort.

Dr. Joseph performs the non-surgical nose job painlessly with a topical anesthetic, and there is no downtime.

While most patients are candidates for the non-surgical nose job, some aren't.  If you have breathing problems or a large nasal hump with a droopy nasal tip, traditional rhinoplasty surgery may be the best option for achieving your goals.

Dr. Joseph is a facial plastic surgeon specializing in permanent non-surgical nose job procedures for over 20 years in West Orange, NJ, USA.  His other specialties include primary rhinoplasty, teen rhinoplasty, ethnic rhinoplasty, revision rhinoplasty, chin implant, neck liposuction, cosmetic ear surgery, eyelid surgery, and permanent nonsurgical facial rejuvenation with microdroplet Silikon®-1000.

For more information on services by Eric M. Joseph, MD, and to view many before and after photos, please visit www,ericmjoseph.com.

Contact: Diana, 973-325-1155, [email protected]

Permanent nonsurgical nosejob with microdroplet Silikon-1000 for repair of a pinched and "operated" looking nasal tip.

Eric M. Joseph, M.D., Board Certified Facial Plastic Surgeon, Rhinoplasty Specialist, 20 Years Experience

SOURCE Eric M. Joseph, M.D.


These press releases may also interest you

at 10:45
The "PCR Markets. Forecasts for qPCR, dPCR, Singleplex & Multiplex Markets and by Application, Product and Place. With Executive and Consultant Guides, Including Customized Forecasting and Analysis. 2023 to 2027" report has been added to...

at 10:30
The "Licensing Deals in Biotechnology 2019-2024" report has been added to ResearchAndMarkets.com's offering. Licensing Deals in Biotechnology provides a detailed understanding and analysis of how and why companies enter licensing deals. Fully...

at 10:30
The "Molecular Diagnostics for Cancer: Markets Forecasts by Cancer Type, Product, and Place with Executive & Consultant Guides and Customization. 2023 to 2027" report has been added to ResearchAndMarkets.com's offering. Exciting technical...

at 10:30
Closed System Transfer Devices Market in terms of revenue was estimated to be worth $1.1 billion in 2024 and is poised to reach $2.5 billion by 2029, growing at a CAGR of 14.5% from 2024 to 2029 according to a new report by MarketsandMarketstm. The...

at 10:30
RIVANNA®, a developer of imaging-based medical solutions, names Craig Loomis as senior director of product management. With over 25 years of extensive experience in global product development and commercialization within the healthcare sector, Mr....

at 10:10
The group division of Ameritas proudly announces its 17th consecutive certification as a BenchmarkPortal Center of Excellence, solidifying its position as a leader in customer service and support excellence. This prestigious recognition for 2023...



News published on and distributed by: